Wendall Wierenga

(Dr. Wendall Wierenga Ph.D.)

Currently holds positions in Concert Pharmaceuticals Inc, Santarus Inc, Crinetics Pharmaceuticals Inc, Onyx Pharmaceuticals Inc, XenoPort Inc and Cytokinetics Inc

Positions
Position Company Period
Director Concert Pharmaceuticals Inc March 13, 2014 -
Executive Vice President - Research and Development Santarus Inc June 20, 2011 -
Independent Chairman of the Board Crinetics Pharmaceuticals Inc Oct. 1, 2015 -
Independent Director Onyx Pharmaceuticals Inc Dec. 1, 1996 -
Independent Director XenoPort Inc Jan. 1, 2000 -
Independent Director Cytokinetics Inc Feb. 9, 2011 -
Independent Director Seelos Therapeutics Inc March 10, 2014 - Jan. 24, 2019
Independent Director Ocera Therapeutics Inc Dec. 19, 2013 - Dec. 11, 2017
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-12-27 2023-12-27
PS Planned sale
5,000 -21.1%
73.60
368,000 USD 		5,000 -21.1% 73.60 368,000 USD
2023-12-27 2023-12-27
PS Planned sale
5,000 -21.1%
73.60
368,000 USD 		5,000 -21.1% 73.60 368,000 USD
2023-08-21 2023-08-21
S Sale
6,020 -24.9%
32.02
192,760 USD 		6,020 -24.9% 32.02 192,760 USD
2023-02-08 2023-02-06
PS Planned sale
7,000 -35.8%
45.00
315,000 USD 		7,000 -35.8% 45.00 315,000 USD
2022-09-01 2022-09-01
PS Planned sale
4,166 -25.5%
52.79
219,923 USD 		4,166 -25.5% 52.79 219,923 USD
2020-04-29 2020-04-28
S Sale
6,666 -100.0%
16.00
106,656 USD 		6,666 -100.0% 16.00 106,656 USD
2020-04-29 2020-04-28
S Sale
3,333 -100.0%
16.00
53,328 USD 		3,333 -100.0% 16.00 53,328 USD
2014-10-24 2014-10-22
B Purchase
20,000 +inf%
1.52
30,364 USD 		20,000 +inf% 1.52 30,364 USD